| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |